The mouse and human Ah receptor differ in recognition of LXXLL motifs

Archives of Biochemistry and Biophysics

Volumn 471, Issue 2, 2008, Pages 215-223

  Flaveny, Colin ^a   Reen, Rashmeet K ^a   Kusnadi, Ann ^a   Perdew, Gary H ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Ah receptor; Coactivators; Dioxin; Glutamine rich; LXXLL; TCDD

Indexed keywords

AMINO ACID; AROMATIC HYDROCARBON RECEPTOR; GLUTAMINE; HYBRID PROTEIN; LIGAND; PROLINE; SERINE; THREONINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GAL4;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE TARGETING; HUMAN; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; PROTEIN MOTIF; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; TRANSACTIVATION;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACIDS, ACIDIC; ANIMALS; BASE SEQUENCE; DNA-BINDING PROTEINS; GLUTAMINE; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROLINE; RECEPTORS, ARYL HYDROCARBON; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; SERINE; THREONINE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 39749191311     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2008.01.014     Document Type: Article

References (42)

1. Denison M.S., and Nagy S.R. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 309-334
2. Poland A., and Knutson J.C. Annu. Rev. Pharmacol. Toxicol. 22 (1982) 517-554
3. Schmidt J.V., Su G.H.-T., Reddy J.K., Simon M.C., and Bradfield C.A. Proc. Natl. Acad. Sci. USA 93 (1996) 6731-6736
4. Abbott B.D., Schmid J.E., Pitt J.A., Buckalew A.R., Wood C.R., Held G.A., and Diliberto J.J. Toxicol. Appl. Pharmacol. 155 (1999) 62-70
5. Lund A.K., et al. Toxicol. Appl. Pharmacol. 193 (2003) 177-187
6. Moriguchi T., Motohashi H., Hosoya T., Nakajima O., Takahashi S., Ohsako S., Aoki Y., Nishimura N., Tohyama C., Fujii-Kuriyama Y., and Yamamoto M. Proc. Natl. Acad. Sci. USA 100 (2003) 5652-5657
7. Hogenesch J.B., Chan W.K., Jackiw V.H., Brown R.C., Gu Y.Z., Pray-Grant M., Perdew G.H., and Bradfield C.A. J. Biol. Chem. 272 (1997) 8581-8593
8. Manchester D.K., Gordon S.K., Golas C.L., Roberts E.A., and Okey A.B. Cancer Res. 47 (1987) 4861-4868
9. Ramadoss P., Petrulis J.R., Hollingshead B.D., Kusnadi A., and Perdew G.H. Biochemistry 43 (2004) 700-709
10. Perdew G.H. Arch. Biochem. Biophys. 291 (1991) 284-290
11. McGuire J., Whitelaw M.L., Pongratz I., Gustafsson J.A., and Poellinger L. Mol. Cell. Biol. 14 (1994) 2438-2446
12. Jain S., Dolwick K.M., Scmidt J.V., and Bradfield C.A. J. Biol. Chem. 269 (1994) 31518-31524
13. Sogawa K., Iwabuchi K., Abe H., and Fuji-Kuriyama A.Y. J. Cancer Res. Clin. Oncol. 121 (1995) 612-620
14. Rowlands J.C., McEwan I.J., and Gustafsson J. Mol. Pharmacol. 50 (1996) 538-548
15. Kohle C., and Bock K.W. Biochem. Pharmacol. 73 (2007) 1853-1862
16. Patel R.D., Kim D.J., Peters J.M., and Perdew G.H. Toxicol. Sci. 89 (2006) 75-82
17. Ikuta T., and Kawajiri K. Exp. Cell Res. 312 (2006) 3585-3594
18. Ohtake F., Takeyama K., Matsumoto T., Kitagawa H., Yamamoto Y., Nohara K., Tohyama C., Krust A., Mimura J., Chambon P., Yanagisawa J., Fujii-Kuriyama Y., and Kato S. Nature 423 (2003) 545-550
19. Ruby C.E., Leid M., and Kerkvliet N. Mol. Pharmacol. 62 (2002) 722-728
20. Hankinson O. Arch. Biochem. Biophys. 433 (2005) 379-386
21. Beischlag T.V., Wang S., Rose D.W., Torchia J., Reisz-Porszasz S., Muhammad K., Nelson W.E., Probst M.R., Rosenfeld M.G., and Hankinson O. Mol. Cell. Biol. 22 (2002) 4319-4333
22. Chen Y.H., Beischlag T.V., Kim J.H., Perdew G.H., and Stallcup M.R. J. Biol. Chem. 281 (2006) 12242-12247
23. Kumar M.B., Tarpey R.W., and Perdew G.H. J. Biol. Chem. 274 (1999) 22155-22164
24. Heery D.M., et al. Nature 387 (1997) 733-736
25. Ding X.F., Anderson C.M., Ma H., Hong H., Uht R.M., Kushner P.J., and Stallcup M.R. Mol. Endocrinol. 12 (1998) 303-313
26. Litterst C.M., and Phitzner E. J. Biol. Chem. 277 (2002) 36052-36060
27. Chang C.Y., et al. Mol. Cell. Biol. 19 (1999) 8226-8239
28. Norris J.D., Paige L.A., Christensen D.J., Chang C.Y., Huacani M.R., Fan D., Hamilton P.T., Fowlkes D.M., and McDonnel D.P. Science 285 (1999) 744
29. Darimont B.D., Wagner R.L., Apriletti J.W., Stallcup M.R., Kushner P.J., Baxter J.D., Fletterick R.J., and Yamamoto K.R. Genes Dev. 12 (1998) 3343-3356
30. Parker D., et al. Mol. Cell. Biol. 19 (1999) 5601-5607
31. McInerney E.M., Rose D.W., Flynn S.E., Westin S., Mullen T.-M., Krones A., Inostroza J., Torchia J., Nolte R.T., Assa-Munt N., Milburn M.V., Glass C.K., and Rosenfeld M.G. Genes Dev. 12 (1998)
32. Zhang S., Rowlands C., and Safe S. Toxicol. Appl. Pharmacol. (2007)
33. Kumar M.B., and Perdew G.H. Gene Expr. 8 (1999) 273-286
34. Kumar M.B., Ramadoss P., Reen R.K., Vanden Heuvel J.P., and Perdew G.H. J. Biol. Chem. 276 (2001) 42302-42310
35. Reen R.K., Cadwallader A., and Perdew G.H. Arch. Biochem. Biophys. 408 (2002) 93-102
36. Adra C.N., Boer P.H., and McBurney M.W. Gene 60 (1987) 65-74
37. Kalkhoven E., Valentine J.E., Heery D.M., and Parker M.G. EMBO J. 17 (1998) 232-243
38. Ramadoss P., and Perdew G.H. Mol. Pharmacol. 66 (2004) 129-136
39. Harper P.A., Golas C.L., and Okey A.B. Cancer Res. 48 (1988) 2388-2395
40. Ko H.P., Okino S.T., Ma Q., and Whitlock Jr. J.P. Mol. Cell. Biol. 17 (1997) 3497-3507
41. Jones L.C., and Whitlock Jr. J.P. J. Biol. Chem. 276 (2001) 25037-25042
42. Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K., and Rosenfeld M.G. Nature 387 (1997) 677-684